Halozyme Therapeutics, Inc. · NASDAQ:HALO
State Street Corp's stake in Halozyme Therapeutics, Inc. fell to 4.90% (Schedule 13G)
Event Mar 31, 2025 · Filed May 13, 2025
State Street Corp's stake in Halozyme Therapeutics, Inc. fell to 4.90%, 6,053,007 shares, as a passive investor on Mar 31, 2025. Filed May 13, 2025 (Schedule 13G).
- Stake
- 4.90%
- Shares
- 6,053,007
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 4.90% | 6,053,007 |